Article Text

Download PDFPDF
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
  1. G Horneff1,2,
  2. F De Bock1,
  3. I Foeldvari3,
  4. H J Girschick4,
  5. H Michels5,
  6. D Moebius6,
  7. H Schmeling2,7,
  8. and the German and Austrian Paediatric Rheumatology Collaborative Study Group
  1. 1
    Department of Paediatrics, Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany
  2. 2
    Department of Paediatrics, University Medical Centre, Martin Luther University, Halle-Wittenberg, Germany
  3. 3
    Paediatric Rheumatology Clinic, AK Eilbeck, Hamburg, Germany
  4. 4
    Department of Paediatrics, University Medical Centre, Wuerzburg, Germany
  5. 5
    Children’s Rheumatology Clinic, Garmisch-Partenkirchen, Germany
  6. 6
    Department of Paediatric Rheumatology, Carl-Thiem Hospital, Cottbus, Germany
  7. 7
    Division of Rheumatology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada
  1. Gerd Horneff, Asklepios Clinic Sankt Augustin, Department of Pediatrics, Arnold-Janssen Str. 29, 53757 Sankt Augustin; G.Horneff{at}Asklepios.com

Footnotes

  • Competing interests: GH has been a member of the advisory boards for Wyeth Biopharma, Muenster, Germany, Abbott Pharma, Wiesbaden, Germany and Essex Pharma, Munich, Germany. GH is conducting clinical studies sponsored by Wyeth Biopharma, Muenster, Germany and Abbott Pharma, Wiesbaden, Germany.

  • Funding: The German Etanercept Registry is sponsored by Wyeth Biopharma, Muenster, Germany.

  • Ethics approval: Ethical approval was granted by the medical ethics committee at the site of the principal investigator (GH; Martin Luther University, Halle-Wittenberg, Germany); written consent was obtained and the data collected in pseudonymous form.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests: GH has been a member of the advisory boards for Wyeth Biopharma, Muenster, Germany, Abbott Pharma, Wiesbaden, Germany and Essex Pharma, Munich, Germany. GH is conducting clinical studies sponsored by Wyeth Biopharma, Muenster, Germany and Abbott Pharma, Wiesbaden, Germany.

  • Funding: The German Etanercept Registry is sponsored by Wyeth Biopharma, Muenster, Germany.

  • Ethics approval: Ethical approval was granted by the medical ethics committee at the site of the principal investigator (GH; Martin Luther University, Halle-Wittenberg, Germany); written consent was obtained and the data collected in pseudonymous form.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.